Lymphocyte-Dependent and Th2 Cytokine-Associated Colitis in Mice Deficient in Wiskott-Aldrich Syndrome Protein

Gastroenterology

Volumn 133, Issue 4, 2007, Pages 1188-1197

  Nguyen, Deanna D ^a,b   Maillard, Michel H ^a,b,c   Cotta de Almeida, Vinicius ^a,b,d   Mizoguchi, Emiko ^a,b   Klein, Christoph ^e   Fuss, Ivan ^f   Nagler, Cathryn ^a,b   Mizoguchi, Atsushi ^a   Bhan, Atul K ^a,b   Snapper, Scott B ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; WISKOTT ALDRICH SYNDROME PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; HISTOLOGY; LAMINA PROPRIA; LYMPHOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; WILD TYPE;

EID: 34848841804     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.07.010     Document Type: Article

References (43)

1. Sartor R.B. Innate immunity in the pathogenesis and therapy of IBD. J Gastroenterol 38 Suppl 15 (2003) 43-47
2. Korzenik J.R. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol 39 (2005) S59-S65
3. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
4. Mizoguchi A., Mizoguchi E., and Bhan A.K. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis 9 (2003) 246-259
5. Elson C.O., Cong Y., McCracken V.J., et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206 (2005) 260-276
6. Kullberg M.C., Jankovic D., Feng C.G., et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 203 (2006) 2485-2494
7. Yen D., Cheung J., Scheerens H., et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116 (2006) 1310-1316
8. Zhang Z., Zheng M., Bindas J., et al. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 12 (2006) 382-388
9. Hue S., Ahern P., Buonocore S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203 (2006) 2473-2483
10. Uhlig H.H., McKenzie B.S., Hue S., et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25 (2006) 309-318
11. Powrie F., Leach M.W., Mauze S., et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1 (1994) 553-562
12. Neurath M.F., Fuss I., Kelsall B.L., et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182 (1995) 1281-1290
13. Davidson N.J., Hudak S.A., Lesley R.E., et al. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 161 (1998) 3143-3149
14. Mizoguchi A., Mizoguchi E., Chiba C., et al. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 183 (1996) 847-856
15. Heller F., Fuss I.J., Nieuwenhuis E.E., et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17 (2002) 629-638
16. Dohi T., Fujihashi K., Rennert P.D., et al. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 189 (1999) 1169-1180
17. Habtezion A., Toivola D.M., Butcher E.C., et al. Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J Cell Sci 118 (2005) 1971-1980
18. Yoshida M., Shirai Y., Watanabe T., et al. Differential localization of colitogenic Th1 and Th2 cells monospecific to a microflora-associated antigen in mice. Gastroenterology 123 (2002) 1949-1961
19. Iqbal N., Oliver J.R., Wagner F.H., et al. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med 195 (2002) 71-84
20. Kanai T., Kawamura T., Dohi T., et al. TH1/TH2-mediated colitis induced by adoptive transfer of CD4+CD45RBhigh T lymphocytes into nude mice. Inflamm Bowel Dis 12 (2006) 89-99
21. Bamias G., Martin C., Mishina M., et al. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 128 (2005) 654-666
22. Iijima H., Takahashi I., Kishi D., et al. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor α chain-deficient mice. J Exp Med 190 (1999) 607-615
23. Boirivant M., Fuss I.J., Chu A., et al. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 188 (1998) 1929-1939
24. Snapper S.B., Rosen F.S., Mizoguchi E., et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9 (1998) 81-90
25. Ochs H.D., and Thrasher A.J. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117 (2006) 725-739
26. Rosen F.S., Cooper M.D., and Wedgwood R.J. The primary immunodeficiencies. N Engl J Med 333 (1995) 431-440
27. Sullivan K.E. Recent advances in our understanding of Wiskott-Aldrich syndrome. Curr Opin Hematol 6 (1999) 8-14
28. Hsieh K.H., Chang M.H., Lee C.Y., et al. Wiskott-Aldrich syndrome and inflammatory bowel disease. Ann Allergy 60 (1988) 429-431
29. Dupuis-Girod S., Medioni J., Haddad E., et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111 (2003) e622-e627
30. Folwaczny C., Ruelfs C., Walther J., et al. Ulcerative colitis in a patient with Wiskott-Aldrich syndrome. Endoscopy 34 (2002) 840-841
31. Schurman S.H., and Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 15 (2003) 446-453
32. Zhang J., Shehabeldin A., da Cruz L.A., et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med 190 (1999) 1329-1342
33. Maillard M.H., Cotta-de-Almeida V., Takeshima F., et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 204 (2007) 381-391
34. Humblet-Baron S., Sather B., Anover S., et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest 117 (2007) 407-418
35. Marangoni F., Trifari S., Scaramuzza S., et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med 204 (2007) 369-380
36. Adriani M., Aoki J., Horai R., et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol 124 (2007) 41-48
37. Snapper S.B., Meelu P., Nguyen D., et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol 77 (2005) 993-998
38. de Noronha S., Hardy S., Sinclair J., et al. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein. Blood 105 (2005) 1590-1597
39. Fuss I.J., Marth T., Neurath M.F., et al. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 117 (1999) 1078-1088
40. Avni O., Lee D., Macian F., et al. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol 3 (2002) 643-651
41. Trifari S., Sitia G., Aiuti A., et al. Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J Immunol 177 (2006) 7451-7461
42. Fuss I.J., Neurath M., Boirivant M., et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157 (1996) 1261-1270
43. Klein C., Nguyen D., Liu C.H., et al. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101 (2003) 2159-2166